Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page interface. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedFooter updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check61 days agoChange DetectedThe Publications section was updated to state that publications are provided voluntarily by the study entrants and are automatically filled from PubMed, and the revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange Detected- Notice about government funding and NIH/CC operating status has been removed from the page.SummaryDifference0.2%

- Check83 days agoChange DetectedThe update shows minor textual edits and a timestamp change, with no changes to core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check111 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference1%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.